一家三甲醫(yī)院近7年輸血不良反應(yīng)的發(fā)生情況及原因分析
發(fā)布時(shí)間:2019-01-21 11:55
【摘要】:目的全面了解該院7年來(lái)輸血不良反應(yīng)的發(fā)生情況,并分析其分布特點(diǎn)和可能的相關(guān)性因素,為深入研究輸血不良反應(yīng)的發(fā)生機(jī)制提供參考。方法通過(guò)手工查閱2010年以來(lái)所有輸血不良反應(yīng)的相關(guān)記錄信息,通過(guò)電子病歷的輸血管理系統(tǒng)查閱2013年來(lái)所有懸浮紅細(xì)胞的有效期和發(fā)血日期。結(jié)果 2010年以來(lái),從該院輸血不良反應(yīng)發(fā)生率來(lái)看,總體發(fā)生率為2.38±0.86‰(349次/151 605 U),血小板為5.64‰,紅細(xì)胞為3.17‰,血漿為1.28‰,冷沉淀為0.94‰。在非溶血性發(fā)熱反應(yīng)中RBC占64%(172/212);過(guò)敏反應(yīng)中血漿占38.1%(40/105),血小板占28.6%(30/105)。消化內(nèi)科和血液內(nèi)科分別占輸血反應(yīng)總數(shù)的32%和21%(110/349和72/349);消化道出血患者發(fā)生的不良反應(yīng)中RBC占93%(63/68);肝病患者發(fā)生的不良反應(yīng)中血漿占71%(17/24);白血病患者發(fā)生的不良反應(yīng)中血小板占57%(20/35)。儲(chǔ)存期為第1、2、3和第4周的懸浮RBC不良反應(yīng)發(fā)生率分別為5.66‰、4.49‰、3.65‰和4.89‰。結(jié)論 RBC發(fā)生的輸血不良反應(yīng)以非溶血性發(fā)熱為主,其他血液成分以過(guò)敏反應(yīng)為主;隨著懸浮RBC儲(chǔ)存時(shí)間的延長(zhǎng),其輸血不良反應(yīng)的發(fā)生率出現(xiàn)先降低后升高的趨勢(shì)。本研究不能完全排除疾病類型和相關(guān)血液成分之間發(fā)生特定輸血不良反應(yīng)的相關(guān)性。
[Abstract]:Objective to investigate the occurrence of adverse reactions of blood transfusion in the past 7 years, and to analyze the distribution characteristics and possible correlation factors in order to provide a reference for the further study of the mechanism of adverse reactions of blood transfusion. Methods the relevant records of all adverse reactions of blood transfusion since 2010 were consulted by hand, and the validity period and date of bleeding of all suspended red blood cells since 2013 were checked through the blood transfusion management system of electronic medical records. Results since 2010, the incidence of adverse reactions of blood transfusion in our hospital was 2.38 鹵0.86 鈥,
本文編號(hào):2412647
[Abstract]:Objective to investigate the occurrence of adverse reactions of blood transfusion in the past 7 years, and to analyze the distribution characteristics and possible correlation factors in order to provide a reference for the further study of the mechanism of adverse reactions of blood transfusion. Methods the relevant records of all adverse reactions of blood transfusion since 2010 were consulted by hand, and the validity period and date of bleeding of all suspended red blood cells since 2013 were checked through the blood transfusion management system of electronic medical records. Results since 2010, the incidence of adverse reactions of blood transfusion in our hospital was 2.38 鹵0.86 鈥,
本文編號(hào):2412647
本文鏈接:http://sikaile.net/linchuangyixuelunwen/2412647.html
最近更新
教材專著